Pharvaris B.V. (PHVS) PT Lowered to $74 at Citizens Ahead of Phase 3 Readout in Q3
Citizens analyst Jonathan Wolleben lowered the price target on Pharvaris B.V. (NASDAQ: PHVS) to $74.00 (from $75.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)